BB Biotech (Germany) Price Prediction
| BBZA Stock | 40.00 0.10 0.25% |
Oversold Vs Overbought
44
Oversold | Overbought |
Using BB Biotech hype-based prediction, you can estimate the value of BB Biotech AG from the perspective of BB Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in BB Biotech to buy its stock at a price that has no basis in reality. In that case, they are not buying BBZA because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
BB Biotech after-hype prediction price | EUR 40.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
BBZA |
BB Biotech After-Hype Price Prediction Density Analysis
As far as predicting the price of BB Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in BB Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of BB Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
BB Biotech Estimiated After-Hype Price Volatility
In the context of predicting BB Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on BB Biotech's historical news coverage. BB Biotech's after-hype downside and upside margins for the prediction period are 38.50 and 41.50, respectively. We have considered BB Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
BB Biotech is very steady at this time. Analysis and calculation of next after-hype price of BB Biotech AG is based on 3 months time horizon.
BB Biotech Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as BB Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading BB Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with BB Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.06 | 1.50 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
40.00 | 40.00 | 0.00 |
|
BB Biotech Hype Timeline
BB Biotech AG is currently traded for 40.00on XETRA Stock Exchange of Germany. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. BBZA is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at -0.06%. %. The volatility of related hype on BB Biotech is about 0.0%, with the expected price after the next announcement by competition of 40.00. The company has price-to-book (P/B) ratio of 1.26. Some equities with similar Price to Book (P/B) outperform the market in the long run. BB Biotech AG recorded a loss per share of 6.37. The entity last dividend was issued on the 27th of March 2023. The firm had 5:1 split on the 29th of March 2016. Assuming the 90 days trading horizon the next forecasted press release will be in 5 to 10 days. Check out BB Biotech Basic Forecasting Models to cross-verify your projections.BB Biotech Related Hype Analysis
Having access to credible news sources related to BB Biotech's direct competition is more important than ever and may enhance your ability to predict BB Biotech's future price movements. Getting to know how BB Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how BB Biotech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| 0BK | MITSUBISHI STEEL MFG | 0.00 | 0 per month | 0.00 | (0.14) | 1.82 | (2.34) | 6.20 | |
| PCHP | SERI INDUSTRIAL EO | 0.00 | 0 per month | 0.00 | (0.10) | 7.86 | (6.03) | 26.24 | |
| LY1 | LION ONE METALS | 0.00 | 0 per month | 2.94 | (0.02) | 5.26 | (5.00) | 14.58 | |
| HAM | Harmony Gold Mining | 0.00 | 0 per month | 0.00 | (0.05) | 7.88 | (5.70) | 16.53 | |
| 5PMA | GREENX METALS LTD | 0.00 | 0 per month | 3.62 | (0.02) | 8.70 | (6.25) | 24.17 | |
| PFX1 | Perma Fix Environmental Services | 0.00 | 0 per month | 2.91 | 0.13 | 7.14 | (6.57) | 16.44 |
BB Biotech Additional Predictive Modules
Most predictive techniques to examine BBZA price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for BBZA using various technical indicators. When you analyze BBZA charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About BB Biotech Predictive Indicators
The successful prediction of BB Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as BB Biotech AG, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of BB Biotech based on analysis of BB Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to BB Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to BB Biotech's related companies.
Story Coverage note for BB Biotech
The number of cover stories for BB Biotech depends on current market conditions and BB Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that BB Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about BB Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
BB Biotech Short Properties
BB Biotech's future price predictability will typically decrease when BB Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of BB Biotech AG often depends not only on the future outlook of the potential BB Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BB Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 55 M | |
| Cash And Short Term Investments | 1.9 M |
Complementary Tools for BBZA Stock analysis
When running BB Biotech's price analysis, check to measure BB Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BB Biotech is operating at the current time. Most of BB Biotech's value examination focuses on studying past and present price action to predict the probability of BB Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BB Biotech's price. Additionally, you may evaluate how the addition of BB Biotech to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |